Salivary Amylase: Digestion and Metabolic Syndrome Catherine Peyrot des GachonsPaul A. S. Breslin Obesity (J McCaffery, Section Editor) 17 September 2016 Article: 102
Viral Hepatitis and Diabetes: Clinical Implications of Diabetes Prevention Through Hepatitis Vaccination Rudruidee KarnchanasornHorng-Yih OuKen C. Chiu Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 13 September 2016 Article: 101
Receptor for Advanced Glycation End Products (RAGE) in Type 1 Diabetes Pathogenesis Sherman S. LeungJosephine M. ForbesDanielle J. Borg Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 09 September 2016 Article: 100
Surgery for Diabetic Eye Complications María H. BerrocalLuis A. AcabaAlexandra Acaba Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors) 09 September 2016 Article: 99
Academic Detailing in Diabetes: Using Outreach Education to Improve the Quality of Care Michael A. Fischer Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors) 01 September 2016 Article: 98
Immune Intervention and Preservation of Pancreatic Beta Cell Function in Type 1 Diabetes Kimber M. SimmonsPeter A. GottliebAaron W. Michels Treatment of Type 1 Diabetes (M Pietropaolo, Section Editor) 25 August 2016 Article: 97
Taking Telemedicine to the Next Level in Diabetes Population Management: a Review of the Endo ECHO Model Matthew F. BouchonvilleMargaret M. PaulSanjeev Arora Health Care Delivery Systems and Implementation in Diabetes (EB Morton-Eggleston and ME McDonnell, Section Editors) 22 August 2016 Article: 96
Biomarkers of β-Cell Stress and Death in Type 1 Diabetes Raghavendra G. MirmiraEmily K. SimsCarmella Evans-Molina Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 19 August 2016 Article: 95
What Are We Learning from the FDA-Mandated Cardiovascular Outcome Studies for New Pharmacological Antidiabetic Agents? Dragana LovreWynn HtunVivian A. Fonseca Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) 19 August 2016 Article: 94
Diet and Gut Microbial Function in Metabolic and Cardiovascular Disease Risk Katie A. MeyerBrian J. Bennett Lifestyle Management to Reduce Diabetes/Cardiovascular Risk (C Shay and B Conway, Section Editors) 19 August 2016 Article: 93
SGLT2 Inhibitors: Benefit/Risk Balance André J. Scheen Pharmacologic Treatment of Type 2 Diabetes (HE Lebovitz and G Bahtiyar, Section Editors) 19 August 2016 Article: 92
Immune-Modulating Therapy for Rheumatologic Disease: Implications for Patients with Diabetes Scott J. PillaAmy Q. QuanNestoras N. Mathioudakis Diabetes Epidemiology (N Maruthur, Section Editor) 15 August 2016 Article: 91
Fenofibrate and Diabetic Retinopathy Jared E. KnickelbeinAkshar B. AbbottEmily Y. Chew Microvascular Complications—Retinopathy (JK Sun and PS Silva, Section Editors) 15 August 2016 Article: 90
The Role of the Intestinal Microbiome in Type 1 Diabetes Pathogenesis James C. NeedellDanny Zipris Pathogenesis of Type 1 Diabetes (A Pugliese, Section Editor) 15 August 2016 Article: 89
